Enveric Biosciences, Inc.
(NASDAQ : ENVB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -0.02%43.940.0%$500.41m
VRXValeant Pharmaceuticals International, Inc. -1.20%27.2214.1%$160.17m
CTLTCatalent, Inc. -0.09%138.052.0%$143.84m
ICLRICON plc -1.00%268.032.8%$113.41m
INDPIndaptus Therapeutics, Inc. -10.62%10.350.0%$112.91m
HZNPHorizon Therapeutics Plc -0.04%107.915.5%$96.48m
JAZZJazz Pharmaceuticals Plc 0.40%132.272.1%$93.75m
PRGOPerrigo Co. Plc 1.29%44.856.9%$80.38m
ARGXargenx SE 1.22%327.510.0%$56.94m
ENDPEndo International Plc 1.65%2.778.5%$53.45m
AXSMAxsome Therapeutics, Inc. -1.51%28.101.8%$49.82m
BHCBausch Health Cos., Inc. -1.20%27.220.0%$48.99m
UTHRUnited Therapeutics Corp. -1.97%201.0914.0%$48.32m
SNOASonoma Pharmaceuticals, Inc. 0.03%5.313.4%$33.01m
ENVBEnveric Biosciences, Inc. -3.92%2.610.0%$20.38m

Company Profile

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.